Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 35, 2022 - Issue 25
Submit an article Journal homepage
179
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Do fetuin-A/apha2-Heremans Schmid-glycoprotein levels have an association with recurrent pregnancy loss?

A. Seval Ozgu-Erdinca Department of Obstetrics and Gynecology, University of Health Sciences, Ankara City Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-6132-5779
ORCID Icon,
Z. Asli Oskovi-Kaplana Department of Obstetrics and Gynecology, University of Health Sciences, Ankara City Hospital, Ankara, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7554-4393
ORCID Icon,
Kudret Erkeneklib Memorial Hospital, Ankara, Turkey
,
Nafiye Yilmaza Department of Obstetrics and Gynecology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey
,
Yaprak Engin-Ustunc Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Womens’ Health Education and Research Hospital, Ankara, Turkey
,
Aykan Yücela Department of Obstetrics and Gynecology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey
&
Dilek Uygura Department of Obstetrics and Gynecology, University of Health Sciences, Ankara City Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0001-8567-9048
ORCID Icon show all
Pages 6942-6945 | Received 24 Jul 2020, Accepted 14 May 2021, Published online: 23 May 2021

References

  • ESHRE (European Society of Human Reproduction and Embryology). Recurrent pregnancy loss – guideline of the European Society of Human Reproduction and Embryology. Belgium: Human Reproduction Open; 2017.
  • Stirrat GM. Recurrent miscarriage. Lancet. 1990;336:673–675.
  • Hong Li Y, Marren A. Recurrent pregnancy loss: a summary of international evidence-based guidelines and practice. Aust J Gen Pract. 2018;47(7):432–436.
  • Practice Committee of the American Society for Reproductive M. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98:1103–1111.
  • Başkak DA, Turğal M, Beksaç S. Obstetric characteristics in women with congenital uterine anomalies who gave a live birth. Gynecol Obstet Reprod Med. 2016;20:77–80.
  • Önalan Etem E, Yüce H, Erol D, et al. Cytogenetic investigation in couples with recurrent abortion and poor obstetric history. Gynecol Obstet Reprod Med. 2010;16:4–8.
  • Astepe BS, Bosgelmez S. Antenatal depression and anxiety among women with threatened abortion: a case-control study. Gynecol Obstet Reprod Med. 2019;26:1–8.
  • Koyun A, Kır Şahin F, Çevrioğlu S, et al. Depression following induced abortion. Gynecol Obstet Reprod Med. 2007;13:80–84.
  • Nergiz Avcıoğlu S, Altınkaya SÖ, Küçük M, et al. The association between platelet indices and clinical parameters in recurrent pregnancy loss. Gynecol Obstet Reprod Med. 2016;20:146–149.
  • Aydın E, Usta T. Assessment of endometrial vascularization with immunohistochemical CD34 assay in recurrent pregnancy loss: a case control study. Gynecol Obstet Reprod Med. 2017;23(2):70–73.
  • Dziegielewska KM, Andersen NA, Lovell D, et al. Fetuin – a new acute phase protein in the adult and in the fetus. Folia Histochem Cytobiol. 1992;30:187–189.
  • Jialal I, Devaraj S, Bettaieb A, et al. Increased adipose tissue secretion of fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome. Atherosclerosis. 2015;241:130–137.
  • Wang H, Sama AE. Anti-inflammatory role of fetuin-A in injury and infection. Curr Mol Med. 2012;12:625–633.]
  • Stefan N, Haring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol. 2013;9:144–152.
  • Iyidir OT, Degertekin CK, Yilmaz BA, et al. Serum levels of fetuin A are increased in women with gestational diabetes mellitus. Arch Gynecol Obstet. 2015;291:933–937.
  • Sanhal CY, Can Kavcar M, Yucel A, et al. Comparison of plasma fetuin A levels in patients with early-onset pre-eclampsia vs late-onset pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2016;200:108–112.
  • Gomez LM, Anton L, Srinivas SK, et al. Effects of increased fetuin-A in human trophoblast cells and associated pregnancy outcomes. Am J Obstet Gynecol. 2012;207(6):484 e1–484.e8.
  • Goldstein SR, Lumsden MA. Abnormal uterine bleeding in perimenopause. Climacteric. 2017;20:414–420.
  • Dziegielewska KM, Matthews N, Saunders NR, et al. alpha 2HS-glycoprotein is expressed at high concentration in human fetal plasma and cerebrospinal fluid. Fetal Diagn Ther. 1993;8:22–27.
  • Chaemsaithong P, Romero R, Tarca AL, et al. Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study. J Matern Fetal Neonatal Med. 2015;28(11):1260–1269.
  • Molvarec A, Kalabay L, Derzsy Z, et al. Preeclampsia is associated with decreased serum alpha(2)-HS glycoprotein (fetuin-A) concentration. Hypertens Res. 2009;32(8):665–669.
  • Iliodromiti S, Vrachnis N, Samoli E, et al. Fetuin A concentration in the second trimester amniotic fluid of fetuses with trisomy 21 appears to be lower: phenotypic considerations. Mediators Inflamm. 2012;2012:138971.
  • Zbucka-Kretowska M, Kuzmicki M, Telejko B, et al. First-trimester irisin and fetuin-A concentration in predicting macrosomia. J Matern Fetal Neonatal Med. 2019;32(17):2868–2873.
  • Briana DD, Boutsikou M, Gourgiotis D, et al. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth. J Matern Fetal Neonatal Med. 2008;21(11):826–830.
  • Bodis J, Peti AM, Sulyok E, et al. Serum and follicular fluid fetuin-A in women undergoing in vitro fertilization. Clin Chem Lab Med. 2014;52(9):1313–1318.
  • Yen M, Donma O, Yildizfer F, et al. Association of fetuin A, adiponectin, interleukin 10 and total antioxidant capacity with IVF outcomes. Iran J Reprod Med. 2014;12:747–754.
  • Ozgu-Erdinc AS, Oskovi-Kaplan ZA, Engin-Ustun Y, et al. Recurrent implantation failure is associated with increased levels of fetuin-A/alpha2-Heremans-Schmid-glycoprotein. Eur J Obstet Gynecol Reprod Biol. 2020;248:1–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.